Cochran John

Insider CIK 1406773 · AQST Director · N Chief Operating Officer

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
AQST Aquestive Therapeutics, In	J Other	2026-10-21	2026-10-23	62,229	—	$0	161,715	SEC↗
N/A Crestline Lending Solution	P Buy	2026-07-24	2026-07-28	7,643	$19.63	$150.0K	7,643	SEC↗
N Crestline Lending Solution	P Buy	2026-07-24	2026-07-28	7,643	$19.63	$150.0K	7,643	SEC↗
AQST Aquestive Therapeutics, In	A Award deriv	2026-06-10	2026-06-12	50,500	—	$0	50,500	SEC↗
AQST Aquestive Therapeutics, In	A Award deriv	2025-06-11	2025-06-12	42,000	$3.41	$143.2K	42,000	SEC↗
AQST Aquestive Therapeutics, In	A Award deriv	2024-06-20	2024-06-21	38,000	—	$0	38,000	SEC↗
AQST Aquestive Therapeutics, In	A Award deriv	2023-06-21	2023-06-23	25,000	—	$0	25,000	SEC↗
AQST Aquestive Therapeutics, In	A Award deriv	2022-06-22	2022-06-24	25,000	—	$0	25,000	SEC↗
AQST Aquestive Therapeutics, In	A Award deriv	2021-06-15	2021-06-17	20,000	—	$0	20,000	SEC↗
AQST Aquestive Therapeutics, In	G Gift	2021-05-10	2021-06-01	37,500	—	$0	99,486	SEC↗
AQST Aquestive Therapeutics, In	J Other	2021-03-12	2021-03-16	23,038	—	$0	98,123	SEC↗
AQST Aquestive Therapeutics, In	J Other	2021-03-12	2021-03-16	11,544	—	$0	117,895	SEC↗
AQST Aquestive Therapeutics, In	J Other	2021-03-12	2021-03-16	8,228	—	$0	106,351	SEC↗
AQST Aquestive Therapeutics, In	J Other	2021-03-12	2021-03-16	19,091	—	$0	136,986	SEC↗
AQST Aquestive Therapeutics, In	A Award deriv	2020-06-16	2020-06-18	14,000	—	$0	14,000	SEC↗
AQST Aquestive Therapeutics, In	A Award deriv	2019-06-13	2019-06-17	13,350	—	$0	13,350	SEC↗
AQST Aquestive Therapeutics, In	A Award deriv	2018-07-24	2018-07-26	26,700	—	$0	26,700	SEC↗